Fortis Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-702
Closed -$28K 342
2020
Q1
$28K Buy
+702
New +$41K 0.02% 215
2019
Q4
Sell
-7,632
Closed -$406K 336
2019
Q3
$406K Sell
7,632
-10,000
-57% -$513K 0.19% 52
2019
Q2
$901K Sell
17,632
-8,615
-33% -$401K 0.44% 30
2019
Q1
$1.36M Sell
26,247
-10,753
-29% -$521K 0.71% 21
2018
Q4
$1.46M Buy
+37,000
New +$1.72M 0.88% 17

Other funds holding SYNH

Fortis Advisors's SYNH Position: Q2 2020 in Review

Fortis Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2020, closing a stake of 702 shares — an estimated $28K sold.

Fortis Advisors first reported a position in SYNH in Q4 2018 and held it in 5 quarters. The position peaked at $1.46M in Q4 2018. 285 funds tracked by Wall St. Rank hold SYNH as of Q2 2020.

  • Fortis Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
  • Fortis Advisors sold 702 Syneos Health, Inc. Class A Common Stock shares in Q2 2020, an estimated $28K.
  • Fortis Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 5 quarters.
  • Fortis Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1.46M in Q4 2018.
  • 285 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.